PMC10291042_01
Echocardiography (on admission) showed pericardial effusion: (A) posterior pericardial cavity of 7.6 mm. (B) Left pericardial cavity of 8.7 mm. (C) Right pericardial cavity of 10.6 mm. (D) Apex of 2.8 mm. (E) Diaphragm of 5.2 mm.
fped-11-1174326-g001.jpg
PMC10291042_01_fped-11-1174326-g001.jpg
F1
Echocardiography showed ejection fraction (EF) of 71%, fraction shortening (FS) of 38%, and moderate pericardial effusion (posterior pericardial cavity of 7.6 mm, left pericardial cavity of 8.7 mm, right pericardial cavity of 10.6 mm, apex of 2.8 mm, diaphragm of 5.2 mm, Figure 1).
Enhanced chest CT (the third day of admission): bilateral lung infection with massive consolidation; enlarged heart, moderate pericardial effusion, pericardial thickening, and enhancement; and a small amount of bilateral pleural effusion.
fped-11-1174326-g002.jpg
PMC10291042_01_fped-11-1174326-g002.jpg
F2
Enhanced chest computed tomography (CT) showed bilateral lung infection, enlarged heart, moderate pericardial effusion, pericardial thickening and enhancement, and a small amount of bilateral pleural effusion (Figure 2).
Ultrasound-guided pericardiocentesis was performed after bedside local anesthesia. Pericardiocentesis extracted 180 ml of pale yellow, clear, non-coagulated pericardial effusion.
fped-11-1174326-g003.jpg
PMC10291042_01_fped-11-1174326-g003.jpg
F3
The needle was inserted 3 cm in the direction of the right scapular region, and 180 ml of pale yellow, clear, non-coagulated pericardial effusion was extracted (Figure 3).
The timeline of patient treatment and disease progression.
fped-11-1174326-g004.jpg
PMC10291042_01_fped-11-1174326-g004.jpg
F4
We have summarized the timeline of patient treatment and disease progression in Figure 4.